• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Rotation Unravels Speculative Plays

Speculative trading in lower-priced stocks has dried up and the small caps have been much tougher.
By JAMES "REV SHARK" DEPORRE
Aug 27, 2020 | 04:35 PM EDT
Stocks quotes in this article: IWM, TSLA, QQQ, WMT, MSFT, ABT

The Dow, the S&P 500, and Russell 2000 (IWM) finished in positive territory as money rotated out of the Nasdaq and Nasdaq 100/Invesco (QQQ) . Breadth was close to even, but it was strength in Walmart (WMT)  and Microsoft (MSFT)  that did the heavy lifting Thursday. Both companies are said to be interested in a deal to buy TikTok.

The wild momentum in Tesla (TSLA)  continued, which helped the bullish cause, but many small stocks were roiled by the surprise of a new rapid Covid-19 test by Abbott (ABT) . Testing stocks and other stocks that are working on Covid treatments were dumped aggressively. There was some movement into the "reopen" stocks, but it was mostly value groups like the financials that benefited from the rotation.

Most notable for aggressive traders is how speculative trading in lower-priced stocks has dried up. The small caps have been much tougher and biotechnology has now been in a downtrend for a month. It isn't terrible action, but it is much more mixed and it is easy to be caught by surprise when momentum quickly fades.

I raised some cash primarily due to taking stops in some weaker positions. While the indexes continue to look quite good, I'm concerned about the trading in the individual stocks that I watch. It may just be a transition to a new crop of leaders, but it has been messy and requires some extra effort to avoid problems.

Have a good evening. I'll see you tomorrow

(MSFT and ABT are holdings in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells these stocks? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, DePorre had no position in the securities mentioned.

TAGS: Investing | Small Cap | Stocks | Biotechnology

More from Stocks

As We Come Back From July 4, Market Fights a Hangover

James "Rev Shark" DePorre
Jul 5, 2022 4:22 PM EDT

After a rough start, we saw strength in some sectors that had taken it on the chin.

What's the Next Move for Crude Oil?

Bruce Kamich
Jul 5, 2022 3:30 PM EDT

A temporary break in oil prices, along with lower interest rates, could be a near-term positive for equity prices.

Can Nvidia Rally and Help the Tech Sector Recover?

Bruce Kamich
Jul 5, 2022 3:00 PM EDT

Why Tuesday could mark the start of a turnaround.

Tesla's Charts Are Resisting a Downside Break

Bruce Kamich
Jul 5, 2022 1:54 PM EDT

Here's what aggressive traders could do.

We Can't Predict the Rest of 2022, but We Must Have a Game Plan

Brad Ginesin
Jul 5, 2022 1:30 PM EDT

Many are forecasting bad times ahead, but are they going to extremes? Here's my strategy for the the second half of the year.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:01 PM EDT PAUL PRICE

    A Recent Director Buy in Children's Place (PLCE)

    Four of the most recent insider trades in Children...
  • 07:34 AM EDT PAUL PRICE

    A $525,000 Vote of Confidence on Macerich (MAC)

  • 09:49 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Stop Wishing, Hoping, and Praying and Take Control...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login